Traws Pharma Inc

Traws Pharma Inc (TRAW) SEC filings

Traws Pharma Inc (TRAW) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M. The TRAW filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Traws Pharma Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

7

8-K

0

Form 4

Recent filings

8-K2.027.019.01

8-K exhibit

EDGAR
8-K3.01

8-K exhibit

EDGAR
8-K8.019.01

8-K exhibit

EDGAR
8-K5.025.079.01

8-K exhibit

EDGAR
8-K7.019.01

8-K exhibit

EDGAR
8-K8.019.01

8-K exhibit

EDGAR
8-K

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all TRAW filings.

Frequently asked questions

What did TRAW just say?

TRAW cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are TRAW SEC filings?

7 cached filings are on this page. EDGAR remains the official archive (CIK 0001130598).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.